Tyrosine kinase inhibitor + ChemotherapyPhase 3 trialInvestigational
regorafenib + Lonsurf
Generic name: regorafenib + trifluridine/tipiracil
How it works
Combination of regorafenib and trifluridine/tipiracil to inhibit cancer cell growth and angiogenesis.
Cancer types
Colorectal Cancer— All patients
Efficacy
Studies show that the combination of regorafenib and Lonsurf can improve overall survival in patients with metastatic colorectal cancer who had failed prior therapies.
Side effects
Severe
This treatment carries a higher risk of serious side effects. Close medical monitoring is required throughout treatment.
This information is provided for general education only and is not medical advice. Always consult a qualified healthcare professional before making treatment decisions.